Evidence map›Paper›PMID 27620482›Full record

ArticleAntimicrobial agents and chemotherapy2016

DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics.

Timothy J Opperman, Steven M Kwasny, Jessica Bo Li, Mark A Lewis, Daniel Aiello, John D Williams, Norton P Peet, Donald T Moir, Terry L Bowlin, Eric C Long

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Escaping ESKAPE resistance:Royal Society open science · 2023
    Article
  3. Novel Pyridazin-3(2ACS medicinal chemistry letters · 2022
    Article
  4. Bis-Indole Alkaloids Isolated from the SpongeInternational journal of molecular sciences · 2022
    Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Timothy J OppermanMicrobiotix, Inc., Worcester, Massachusetts, USA topperman@microbiotix.com eclong@iupui.edu.
Steven M KwasnyMicrobiotix, Inc., Worcester, Massachusetts, USA.
Jessica Bo LiDepartment of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.
Mark A LewisDepartment of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA.
Daniel AielloMicrobiotix, Inc., Worcester, Massachusetts, USA.
John D WilliamsMicrobiotix, Inc., Worcester, Massachusetts, USA.
Norton P PeetMicrobiotix, Inc., Worcester, Massachusetts, USA.
Donald T MoirMicrobiotix, Inc., Worcester, Massachusetts, USA.
Terry L BowlinMicrobiotix, Inc., Worcester, Massachusetts, USA.
Eric C LongDepartment of Chemistry and Chemical Biology, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, USA topperman@microbiotix.com eclong@iupui.edu.
Microbiotix (United States) · USIndiana University – Purdue University Indianapolis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported the synthesis and biological activity of a series of cationic bis-indoles with potent, broad-spectrum antibacterial properties. Here, we describe mechanism of action studies to test the hypothesis that these compounds bind to DNA and that this target plays an important role in their antibacterial outcome. The results reported here indicate that the bis-indoles bind selectively to DNA at A/T-rich sites, which is correlated with the inhibition of DNA and RNA synthesis in representative Gram-positive (

Indexed as

Anti-Bacterial AgentsDNAEscherichia coliHeLa CellsHumansImidazolesIndolesMicrobial Sensitivity TestsMicroscopy, FluorescenceMolecular Targeted TherapySOS Response, GeneticsStaphylococcus aureusAnti-Bacterial AgentsDNAImidazolesIndolesMBX 1066

Identifiers

PMID27620482
PMCPMC5118985
OpenAlexW2519162716

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.